Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
3.240
+0.640 (24.62%)
At close: Oct 23, 2026, 4:00 PM EDT
3.260
+0.020 (0.62%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $412.31 million as of October 23, 2026. It is the 15,904th most valuable company in the world and the 2,866th biggest in the United States. Its market cap has increased by 159.08% in one year.
Market Cap
412.31M
Enterprise Value
356.09M
1-Year Change
159.08%
Global Rank
Country Rank
#2,866 United States
Category
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $412.31M, an increase of 252.29%. That is a compound annual growth rate of 25.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 412.31M | 67.40% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scribe Therapeutics | 369.36M |
| Fennec Pharmaceuticals | 367.15M |
| Kyverna Therapeutics | 363.64M |
| Orchestra BioMed Holdings | 349.81M |
| Opus Genetics | 347.76M |
| Relmada Therapeutics | 347.74M |
| vTv Therapeutics | 346.03M |
| Capricor Therapeutics | 345.93M |